Showing 22,201 - 22,220 results of 226,405 for search '(( a ((((linear decrease) OR (a decrease))) OR (larger decrease)) ) OR ( a large decrease ))', query time: 1.25s Refine Results
  1. 22201
  2. 22202

    Image_1_GPER-Induced ERK Signaling Decreases Cell Viability of Hepatocellular Carcinoma.tif by Yu-an Qiu (10272836)

    Published 2021
    “…<p>Hepatocellular carcinoma (HCC) is an aggressive malignancy with a poor prognosis. Effective biomarkers and specific therapeutic targets for HCC are therefore urgently needed. …”
  3. 22203

    p62 impairs mitochondrial function in transfected cells: decreased oxidative phosphorylation and increased glycolysis. by Kasey L. Jackson (3633022)

    Published 2017
    “…A) Basal oxygen consumption, i.e., oxidative phosphorylation, was decreased in the p62 group compared to the two control groups (ANOVA/Bonferroni, p < 0.001). …”
  4. 22204
  5. 22205

    DFPM treated-wild type (Col-0) seedlings exhibit decreased cell viability in roots. by Hans-Henning Kunz (662438)

    Published 2016
    “…<p>A) Root cell viability of Col-0 root tissues decreased as concentrations of DFPM increased. …”
  6. 22206
  7. 22207
  8. 22208
  9. 22209
  10. 22210
  11. 22211
  12. 22212
  13. 22213
  14. 22214

    Data_Sheet_1_Decreased Exosomal Acetylcholinesterase Activity in the Plasma of Patients With Parkinson’s Disease.DOCX by Kyu Hwan Shim (9117111)

    Published 2021
    “…Remarkably, exosomal AChE activity was significantly decreased in PD compared to HC (P = 0.002). Moreover, exosomal AChE activity in PD revealed a strong negative correlation with disease severity, including H&Y (P = 0.007) and UPDRS part III (P = 0.047) scores. …”
  15. 22215
  16. 22216
  17. 22217

    Belinostat decreases both male and female bladder weights in transgenic superficial bladder cancer mice by Michael T Buckley (37161)

    Published 2011
    “…Normal non-transgenic mouse bladders weigh approximately 10.0 mg at the same age, and Ha-transgenic mice with superficial bladder cancer have a 3 fold and higher bladder weight. , Male belinostat-treated mice (n = 4, 327.5 mg average weight) showed a two-fold decrease (50%, p = 0.03) in bladder weight versus control (n = 4, 652.5 mg average weight). , Female belinostat-treated mice (n = 5, 34.0 mg average weight) showed a 36% decrease (p = 0.04) in bladder weight versus control (n = 6, 53.3 mg average weight).…”
  18. 22218
  19. 22219
  20. 22220